Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
AI use in schools: How districts are making sure it's used as a study aid
Recommended
How to prepare for the Fed's forthcoming interest rate cuts
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prothena Corp
(NQ:
PRTA
)
21.71
+0.46 (+2.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
417,743
Open
21.53
Bid (Size)
19.91 (3)
Ask (Size)
25.00 (2)
Prev. Close
21.25
Today's Range
21.02 - 22.06
52wk Range
18.69 - 56.63
Shares Outstanding
45,047,449
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
August 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Performance
YTD
-43.67%
-43.67%
1 Month
-12.42%
-12.42%
3 Month
+8.82%
+8.82%
6 Month
-22.96%
-22.96%
1 Year
-59.59%
-59.59%
More News
Read More
Prothena to Report Second Quarter 2024 Financial Results on August 8
August 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
March 13, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Prothena Corp
February 16, 2024
Via
Benzinga
Prothena Corp: Q4 Earnings Insights
February 15, 2024
Via
Benzinga
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
May 28, 2024
From
Prothena Corporation plc
Via
Business Wire
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
May 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report First Quarter 2024 Financial Results on May 8
May 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Earnings Scheduled For February 15, 2024
February 15, 2024
Via
Benzinga
Earnings Outlook For Prothena Corp
February 14, 2024
Via
Benzinga
Navigating 5 Analyst Ratings For Prothena Corp
January 25, 2024
Via
Benzinga
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Prothena to Participate in Upcoming Healthcare Conferences
March 05, 2024
From
Prothena Corporation plc
Via
Business Wire
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today
January 22, 2024
Via
Benzinga
Demystifying Prothena Corp: Insights From 5 Analyst Reviews
January 09, 2024
Via
Benzinga
Prothena Appoints David Ford to Newly Created Chief People Officer Position
March 04, 2024
From
Prothena Corporation plc
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
February 21, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
February 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
February 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.